1. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312:82-90. PMID:
3880598.
2. Khan RN, Matharoo-Ball B, Arulkumaran S, Ashford ML. Potassium channels in the human myometrium. Exp Physiol 2001;86:255-264. PMID:
11429642.
3. Brainard AM, Korovkina VP, England SK. Potassium channels and uterine function. Semin Cell Dev Biol 2007;18:332-339. PMID:
17596977.
4. Morrison JJ, Ashford ML, Khan RN, Smith SK. The effects of potassium channel openers on isolated pregnant human myometrium before and after the onset of labor: potential for tocolysis. Am J Obstet Gynecol 1993;169:1277-1285. PMID:
8238196.
5. Cheuk JM, Hollingsworth M, Hughes SJ, Piper IT, Maresh MJ. Inhibition of contractions of the isolated human myometrium by potassium channel openers. Am J Obstet Gynecol 1993;168:953-960. PMID:
8456909.
6. Okawa T, Vedernikov YP, Saade GR, Longo M, Olson GL, Chwalisz K, et al. Roles of potassium channels and nitric oxide in modulation of uterine contractions in rat pregnancy. Am J Obstet Gynecol 1999;181:649-655. PMID:
10486479.
7. Sadlonova V, Franova S, Dokus K, Janicek F, Visnovsky J, Sadlonova J. Participation of BKCa2+ and KATP potassium ion channels in the contractility of human term pregnant myometrium in
in vitro conditions. J Obstet Gynaecol Res 2011;37:215-221. PMID:
21272145.
8. Novakovic R, Milovanovic S, Protic D, Djokic J, Heinle H, Gojkovic-Bukarica L. The effect of potassium channel opener pinacidil on the non-pregnant rat uterus. Basic Clin Pharmacol Toxicol 2007;101:181-186. PMID:
17697038.
9. Mandi G, Sarkar SN, Mishra SK, Raviprakash V. Effects of calcium channel blocker, mibefradil, and potassium channel opener, pinacidil, on the contractile response of mid-pregnant goat myometrium. Indian J Exp Biol 2005;43:795-801. PMID:
16187530.
10. Aguilar-Bryan L, Clement JP 4th, Gonzalez G, Kunjilwar K, Babenko A, Bryan J. Toward understanding the assembly and structure of KATP channels. Physiol Rev 1998;78:227-245. PMID:
9457174.
11. Curley M, Cairns MT, Friel AM, McMeel OM, Morrison JJ, Smith TJ. Expression of mRNA transcripts for ATP-sensitive potassium channels in human myometrium. Mol Hum Reprod 2002;8:941-945. PMID:
12356945.
12. Xu C, You X, Gao L, Zhang L, Hu R, Hui N, et al. Expression of ATP-sensitive potassium channels in human pregnant myometrium. Reprod Biol Endocrinol 2011;9:35PMID:
21418633.
13. Sasaki A, Tempst P, Liotta AS, Margioris AN, Hood LE, Kent SB, et al. Isolation and characterization of a corticotropin-releasing hormone-like peptide from human placenta. J Clin Endocrinol Metab 1988;67:768-773. PMID:
3262120.
14. Goland RS, Wardlaw SL, Blum M, Tropper PJ, Stark RI. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy. Am J Obstet Gynecol 1988;159:884-890. PMID:
2845784.
15. Sasaki A, Shinkawa O, Margioris AN, Liotta AS, Sato S, Murakami O, et al. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. J Clin Endocrinol Metab 1987;64:224-229. PMID:
3491832.
16. Goland RS, Wardlaw SL, Stark RI, Brown LS Jr, Frantz AG. High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 1986;63:1199-1203. PMID:
3020078.
17. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med 1995;1:460-463. PMID:
7585095.
18. Korebrits C, Ramirez MM, Watson L, Brinkman E, Bocking AD, Challis JR. Maternal corticotropin-releasing hormone is increased with impending preterm birth. J Clin Endocrinol Metab 1998;83:1585-1591. PMID:
9589660.
19. Warren WB, Patrick SL, Goland RS. Elevated maternal plasma corticotropin-releasing hormone levels in pregnancies complicated by preterm labor. Am J Obstet Gynecol 1992;166:1198-1204. PMID:
1566770.
20. Makrigiannakis A, Semmler M, Briese V, Eckerle H, Minas V, Mylonas I, et al. Maternal serum corticotropin-releasing hormone and ACTH levels as predictive markers of premature labor. Int J Gynaecol Obstet 2007;97:115-119. PMID:
17368647.
21. Sawada K, Morishige K, Hashimoto K, Tasaka K, Kurachi H, Murata Y, et al. Gestational change of K+ channel opener effect is correlated with the expression of uterine KATP channel subunits. Eur J Obstet Gynecol Reprod Biol 2005;122:49-56. PMID:
16154039.
22. Campbell EA, Linton EA, Wolfe CD, Scraggs PR, Jones MT, Lowry PJ. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 1987;64:1054-1059. PMID:
3494036.
23. Guendelman S, Kosa JL, Pearl M, Graham S, Kharrazi M. Exploring the relationship of second-trimester corticotropin releasing hormone, chronic stress and preterm delivery. J Matern Fetal Neonatal Med 2008;21:788-795. PMID:
19031275.
24. Zhang LM, Wang YK, Hui N, Sha JY, Chen X, Guan R, et al. Corticotropin-releasing hormone acts on CRH-R1 to inhibit the spontaneous contractility of non-labouring human myometrium at term. Life Sci 2008;83:620-624. PMID:
18805429.
25. Simpkin JC, Kermani F, Palmer AM, Campa JS, Tribe RM, Linton EA, et al. Effects of corticotrophin releasing hormone on contractile activity of myometrium from pregnant women. Br J Obstet Gynaecol 1999;106:439-445. PMID:
10430194.
26. Tyson EK, Smith R, Read M. Evidence that corticotropin-releasing hormone modulates myometrial contractility during human pregnancy. Endocrinology 2009;150:5617-5625. PMID:
19846610.
27. Hillhouse EW, Grammatopoulos DK. Control of intracellular signalling by corticotropin-releasing hormone in human myometrium. Front Horm Res 2001;27:66-74. PMID:
11450436.
28. Aggelidou E, Hillhouse EW, Grammatopoulos DK. Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells. Proc Natl Acad Sci USA 2002;99:3300-3305. PMID:
11854458.
29. Grammatopoulos DK. The role of CRH receptors and their agonists in myometrial contractility and quiescence during pregnancy and labour. Front Biosci 2007;12:561-571. PMID:
17127317.
30. Quartero HW, Fry CH. Placental corticotrophin releasing factor may modulate human parturition. Placenta 1989;10:439-443. PMID:
2789379.
31. Mignot TM, Paris B, Carbonne B, Vauge C, Ferré F, Vaiman D. Corticotropin-releasing hormone effects on human pregnant vs. nonpregnant myometrium explants estimated from a mathematical model of uterine contraction. J Appl Physiol 1985;2005:1157-1163.
32. Grammatopoulos D, Thompson S, Hillhouse EW. The human myometrium expresses multiple isoforms of the corticotropin-releasing hormone receptor. J Clin Endocrinol Metab 1995;80:2388-2393. PMID:
7629235.
33. Hillhouse EW, Randeva H, Ladds G, Grammatopoulos D. Corticotropin-releasing hormone receptors. Biochem Soc Trans 2002;30:428-432. PMID:
12196108.
34. Li C, Chen P, Vaughan J, Blount A, Chen A, Jamieson PM, et al. Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Endocrinology 2003;144:3216-3224. PMID:
12810578.
35. Karteris E, Hillhouse EW, Grammatopoulos D. Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility. Endocrinology 2004;145:890-900. PMID:
14592950.
36. Jovanović A, Jovanović S. SURA2 targeting for cardioprotection? Curr Opin Pharmacol 2009;9:189-193. PMID:
19084477.
37. Du Q, Jovanović S, Sukhodub A, Jovanović A. Infection with AV-SUR2A protects H9C2 cells against metabolic stress: a mechanism of SUR2A-mediated cytoprotection independent from the K(ATP) channel activity. Biochim Biophys Acta 2010;1803:405-415. PMID:
20123112.
38. Ballantyne T, Du Q, Jovanović S, Neemo A, Holmes R, Sinha S, et al. Testosterone protects female embryonic heart H9c2 cells against severe metabolic stress by activating estrogen receptors and up-regulating IES SUR2B. Int J Biochem Cell Biol 2013;45:283-291. PMID:
23085378.
39. Jovanović S, Ballantyne T, Du Q, Blagojević M, Jovanović A. Phenylephrine preconditioning in embryonic heart H9c2 cells is mediated by up-regulation of SUR2B/Kir6.2: a first evidence for functional role of SUR2B in sarcolemmal KATP channels and cardioprotection. Int J Biochem Cell Biol 2016;70:23-28. PMID:
26556311.